Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stockpile
Pharma
Lilly scores $720M deal with U.S. for latest antibody treatment
The U.S. has agreed to a $720M deal for Eli Lilly's latest antibody treatment, bebtelovimab. Lilly will supply 600,000 courses by the end of March.
Kevin Dunleavy
Feb 11, 2022 8:52am
BARDA taps Emergent for extra anthrax vaccine doses
Jul 14, 2020 12:12pm
Inside Novartis' fight to keep its supply chain open amid COVID
Jun 4, 2020 11:20am
U.K. tells drugmakers to stockpile in case Brexit goes bad
Aug 23, 2018 12:07pm
Sanofi offloads smallpox vaccine business in $125M deal
Jul 18, 2017 7:19am
Emergent's anthrax vax gets $1B vote of confidence
Dec 12, 2016 12:12pm
